News

Archives
1 Apr 2013

PIK3CA subgroup analysis included as a new secondary endpoint

In the light of the recent data on PIK3CA, we have included PIK3CA subgroup analysis as a new secondary endpoint, and we are currently working on how best to incorporate PIK3CA with aspirin.   PIK3CA has the promise to be one of most important biomarkers in CRC